Century Therapeutics
IPSC
36 hedge funds and large institutions have $491M invested in Century Therapeutics in 2021 Q2 according to their latest regulatory filings, with 36 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
30.79% more ownership
Funds ownership: 0% → 30.79% (+31%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$126M |
| 2 |
CC
Casdin Capital
New York
|
+$81.4M |
| 3 |
SM
SB Management
Abu Dhabi,
United Arab Emirates
|
+$50.7M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$25.5M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
+$25.1M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GCM
26
Ghisallo Capital Management
Boston,
Massachusetts
| $880K | +$761K | +30,000 | New |
|
27
Vanguard Group
Malvern,
Pennsylvania
| $880K | +$761K | +30,000 | New |
|
28
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $675K | +$584K | +23,001 | New |
|
29
Qube Research & Technologies (QRT)
London,
United Kingdom
| $586K | +$507K | +19,979 | New |
|
|
SSA
30
Schonfeld Strategic Advisors
New York
| $531K | +$459K | +18,100 | New |
|
31
Wellington Management Group
Boston,
Massachusetts
| $494K | +$427K | +16,821 | New |
|
32
Norges Bank
Oslo,
Norway
| $293K | +$254K | +10,000 | New |
|
33
Tudor Investment Corp
Stamford,
Connecticut
| $205K | +$178K | +7,000 | New |
|
34
UBS Group
Zurich,
Switzerland
| $30K | +$26.2K | +1,032 | New |
|
35
Legal & General Group
London,
United Kingdom
| $29K | +$25.4K | +1,000 | New |
|
36
Bank of America
Charlotte,
North Carolina
| – | +$254 | +10 | New |
|
IPSC Hedge Fund Activity: Q2 2021 in Review
36 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Century Therapeutics (IPSC) for Q2 2021, worth a combined $491M.
Buyers outnumbered sellers: 36 funds opened new IPSC positions and 0 closed out — a net gain of 36 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $126M.
- 36 institutional investors held Century Therapeutics (IPSC) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $491M of Century Therapeutics stock for Q2 2021.
- 36 funds opened new Century Therapeutics positions in Q2 2021 and 0 closed out, a net change of +36 holders.
- The largest Century Therapeutics buyer in Q2 2021 was Fidelity Investments, an estimated $126M added.
Based on aggregated 13F filings for Q2 2021.